North African genetic variation of cytochrome and sulfotransferase genes

  1. Gaibar, María 1
  2. Arqués, Meritxell 2
  3. Fernández-Santander, Ana 1
  4. Novillo, Apolonia 1
  5. Romero-Lorca, Alicia 1
  6. Wei Li, Qi 1
  7. Esteban, M. Esther 2
  1. 1 Universidad Europea de Madrid
    info

    Universidad Europea de Madrid

    Madrid, España

    ROR https://ror.org/04dp46240

  2. 2 Universitat de Barcelona
    info

    Universitat de Barcelona

    Barcelona, España

    ROR https://ror.org/021018s57

Revista:
International Journal of Modern Anthropology

ISSN: 1737-8176,  1737-7374

Año de publicación: 2015

Volumen: 1

Número: 8

Páginas: 13

Tipo: Artículo

DOI: 10.4314/IJMA.V1I8.1 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: International Journal of Modern Anthropology

Objetivos de desarrollo sostenible

Resumen

This review is focused on the genetic variation of sulfotransferases (SULTs) andcytochromes (CYPs) genes among different ethnic groups, mainly focusing in variation inNorth African populations. Polymorphisms of SULTs and CYPs proteins are associated withaltered enzymatic activity and physical characteristics. Single nucleotide polymorphisms (SNP)in these genes have shown relevant ethnic differences among Sub-Saharan African andEuropean groups that might contribute to understand the variability in drug metabolism andrisk to certain cancers that has been described among these two groups. Taking into accountthat North African populations have been scarcely described for these genes, and consideringthe rich genetic past of this region with a noticeable Sub-Saharan African contribution to theiroriginal background, it is interesting a revision and description of some relevantpolymorphisms (González-Pérez et al. 2010; Hen et al. 2012)

Referencias bibliográficas

  • Adjei AA, Thomae BA, Prondzinski JL, Eckloff BW, Wieben ED & Weinshilboum RM 2003 Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics. British Journal of Pharmacology 139 1373– 1382.
  • Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics. 2001 Feb;11(1):57-68.
  • Charles N. Falany,a, Dongning He,a Li Li,a Josie L. Falany,a Teresa W. Wilborn,b Thomas A. Kocarek C and Runge-Morrisc M. Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF). J Steroid Biochem Mol Biol. Author manuscript; available in PMC 2013 Dec 7. Published in final edited form as: J Steroid Biochem Mol Biol. 2009 Mar; 114(0): 10.1016/j.jsbmb.2009.02.009.
  • Cole GB1, Keum G, Liu J, Small GW, Satyamurthy N, Kepe V, Barrio JR. Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6222-7. doi: 10.1073/pnas.0914904107. Epub 2010 Mar 19.
  • Coughtrie MW, Gilissen RA, Shek B. et al., “Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations,” Biochemical Journal, vol. 337, no. 1, pp. 45–49, 1999. Gamage N, Barnett A, Hempel N, Duggleby R, Windmill K, Martin J, and McManus M. Human Sulfotransferases and Their Role in Chemical Metabolism. 2006. sciences, vol. 90, no. 1, pp. 5-22
  • Garsa AA, Howard L McLeod and Sharon Marsh. CYP3A4 and CYP3A5 genotyping by Pyrosequencing. BMC Medical Genetics 2005, 6:19 doi:10.1186/1471-2350-6-19 González-Pérez E, Esteban E, Via M, Gayà-Vidal M, Athanasiadis G, Dugoujon JM, Luna F, Mesa MS, Fuster V, Kandil M, Harich N, Bissar-Tadmouri N, Saetta A, Moral P. Population relationships in the Mediterranean revealed by autosomal genetic data (Alu and Alu/STR compound systems). Am J Phys Anthropol. 2010 Mar;141(3):430-9.
  • Hansruedi Glatt and Walter Meinl. Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn-Schmiedeberg's Archives of Pharmacology. January 2004, Volume 369, Issue 1, pp 55-68
  • Henn BM, Botigué LR, Gravel S, Wang W, Brisbin A, Byrnes JK, Fadhlaoui-Zid K, Zalloua PA, Moreno-Estrada A, Bertranpetit J, Bustamante CD, Comas D. Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet. 2012 Jan;8(1):e1002397.
  • Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Boguski, M. S., Schuetz, E. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genet. 27: 383-391, 2001.
  • Lamba J, Hebert JM, Schuetz EG, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenet Genomics. 2012;22(7):555.
  • Lopes BR, Mariana Emerenciano, Bruno Alves Aguiar Gonçalves, Tállita Meciany Vieira, Ana Rossini, and Maria S. Pombo-de-Oliveira. Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia. PLoS One. 2015; 10(5): e0127308.
  • O’Mara TA, Ferguson K, Fahey P, Marquart L, Yang HP, Lissowska J, Chanock S, Garcia-Closas M, Thompson DJ, Healey CS. et al. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk. Twin Res Hum Genet. 2011;14(4):328–332. doi: 10.1375/twin.14.4.328.
  • Sánchez-Cuenca D. 2014. Genetic diversity drug metabolizing enzymes in North African populations. Master Dissertation Thesis. Universitat de Barcelona. Serdal Arslan, Yavuz Siling, Hatice Pinarbasi. Sulfotransferase 1A1 Arg213His polymorphism and prostate cancer risk. Exp Ther Med. 2011 Nov-Dec; 2(6): 1159– 1162.
  • Shah IA, Bhat GA, Mehta P, Lone MM, Dar NA. Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a casecontrol study from Kashmir, India. Dis Esophagus. 2015 Oct 12. doi: 10.1111/dote.12427
  • Swati Nagar, Susan Walther and Rebecca L. Blanchard. Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein Degradation. Molecular Pharmacology June 2006 vol. 69 no. 6 2084-2092
  • Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA, Di Rienzo A. CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet. 2004 Dec;75(6):1059-69.
  • Wencheng Li and Min Gu. SULT1A1 Arg213His Polymorphism is Associated with Bladder Cancer Risk: A Meta-Analysis. Med Sci Monit. 2014; 20: 1590–1595. Yiwei Jiang, Liheng Zhou, Tingting Yan, Zhenzhou Shen, Zhimin Shao and Jinsong Lu. Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue. Jiang et al. Journal of Experimental & Clinical Cancer Research 2010.
  • Yousef AM, Bulatova NR, Newman W, Hakooz N, Ismail S, Qusa H, Zahran F, Anwar Ababneh N, Hasan F, Zaloom I, Khayat G, Al-Zmili R, Naffa R, Al-Diab O. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Mol Biol Rep. 2012;39:9423–9403